Glaxosmithkline Share News (GSK)

London close: Astrazeneca leads FTSE higher on bid speculation

- Healthcare stocks lift FTSE - German PMI data drives sentiment - Investors look ahead to Draghi speech - UK retail sales disappoint techMARK 2,819.77 +0.82% FTSE 100 6,777.66 +0.33% FTSE 250 15,838.57 +0.57% London's blue chips ended Thursday's session on a positive note, led by Astrazeneca. Inc

MARKET COMMENT: UK Gains Held Back By Miners

Pfizer back for AstraZeneca? Year-end move seen most likely

* AstraZeneca can invite Pfizer to talks from Aug. 26 * But UK drugmaker seen unlikely to make early move * Pfizer still looking at large acquisitions By Ben Hirschler LONDON, Aug 21 (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, f

London midday: UK stocks advance as investors shrug off weak data

- Mining stocks fall as Chinese data weakens - Eurozone PMIs and UK retail sales disappoint - US data, Jackson Hole ahead techMARK 2,810.76 +0.50% FTSE 100 6,772.04 +0.25% FTSE 250 15,797.15 +0.31% Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursda

UK MIDDAY BRIEFING: Drug Makers Among FTSE 100 Leaders

UK WINNERS & LOSERS: Drugs Giants Among Top FTSE 100 Gainers

TOP NEWS: UK Retail Sales Growth Falls Short But Budget Gap Shrinks

MARKET COMMENT: Quindell Weighs On AIM As London Main Market Gains

Skyepharma Trading As Expected As Loss Widens On Bond Settlement

UK MORNING BRIEFING: Flat Start As Investors Mull Central Bank Votes

Glaxo Receives US Approval For Asthma Treatment Arnuity Ellipta

MEDIA-Mylan makes second round of bidding for Glaxo mature-drug portfolio - WSJ

-- Source link: (http://on.wsj.com/1rmp9p7) -- Note: Reuters has not verified this story and does not vouch for its accuracy

P&G eyes Duracell, Braun in sweeping brand culling -sources

By Olivia Oran and Soyoung Kim NEW YORK, Aug 18 (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said.Read more

RPT-INSIGHT-Extreme medicine: The search for new antibiotics

(Repeats Sunday story with no changes) * World crying out for new antibiotics as superbugs evolve * Scientists seek new chemistry in hard-to-reach places * "Back to nature" search aided by genome mining technology By Kate Kelland and Ben Hirschler NORWICH, England, A

INSIGHT-Extreme medicine: The search for new antibiotics

* World crying out for new antibiotics as superbugs evolve * Scientists seek new chemistry in hard-to-reach places * "Back to nature" search aided by genome mining technology By Kate Kelland and Ben Hirschler NORWICH, England, Aug 17 (Reuters) - Pampering leafcutter ants w